Literature DB >> 26295355

A comparison of relative resource use and quality in Medicare Advantage health plans versus traditional Medicare.

Bruce E Landon1, Alan M Zaslavsky, Robert Saunders, L Gregory Pawlson, Joseph P Newhouse, John Z Ayanian.   

Abstract

OBJECTIVES: Prior analyses of Medicare health plans have examined either utilization of services or quality of care, but not both jointly. Our objective was to compare utilization and quality for Medicare Advantage (MA) enrollees with diabetes or cardiovascular disease to that for similarly defined traditional Medicare (TM) beneficiaries. STUDY
DESIGN: Cross-sectional matched observational study using data for 2007.
METHODS: We obtained individual-level Healthcare Effectiveness Data and Information Set (HEDIS) relative resource use (RRU) and quality data for patients enrolled in MA, and then developed comparable claims-based measures for matched samples of TM beneficiaries. MAIN OUTCOME MEASURES: utilization levels for inpatient care, evaluation and management services, and surgery; number of emergency department (ED) and inpatient visits; and quality of ambulatory care measures.
RESULTS: We studied approximately 680,000 MA health maintenance organization (HMO) enrollees with diabetes and 270,000 HMO enrollees with cardiovascular conditions. For both conditions and almost all major strata, the RRU was lower for those enrolled in MA than for those in TM. Spending for those with diabetes was $5223 for MA HMO enrollees compared with $6413 for those in TM (cost ratio, 0.81; P < .001). ED utilization rates were consistently lower in MA than TM (567 vs 719 visits/1000 enrollees; rate ratio, 0.79; P < .001). Health plans that are more established, nonprofit, and/or larger generally had lower resource use and better relative quality than did smaller, newer, for-profit HMOs or preferred provider organizations.
CONCLUSIONS: RRU for those with diabetes or cardiovascular disease is lower in MA, while quality of care is higher. Better MA plans may add value to the care of these major chronic medical conditions.

Entities:  

Mesh:

Year:  2015        PMID: 26295355      PMCID: PMC6365159     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

1.  Paying Medicare Advantage plans: To level or tilt the playing field.

Authors:  Jacob Glazer; Thomas G McGuire
Journal:  J Health Econ       Date:  2016-12-29       Impact factor: 3.883

2.  Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.

Authors:  Bruce E Landon; Alan M Zaslavsky; Jeffrey Souza; John Z Ayanian
Journal:  J Gen Intern Med       Date:  2018-02-09       Impact factor: 5.128

3.  Association Between Medicare Program Type and Health Care Access, Acute Care Utilization, and Affordability Among Adults With Cardiovascular Disease.

Authors:  Andrew S Oseran; Tianyu Sun; Rahul Aggarwal; Ashley Kyalwazi; Robert W Yeh; Rishi K Wadhera
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-09-02

4.  Effect of Medicare Advantage on health care use and care dissatisfaction in mental illness.

Authors:  Sungchul Park
Journal:  Health Serv Res       Date:  2022-02-17       Impact factor: 3.734

5.  Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare.

Authors:  Kelly E Anderson; Daniel Polsky; Sydney Dy; Aditi P Sen
Journal:  Health Serv Res       Date:  2021-12-14       Impact factor: 3.734

6.  Use of diabetes medications in traditional Medicare and Medicare Advantage.

Authors:  Bruce E Landon; Alan M Zaslavsky; Jeffrey Souza; John Z Ayanian
Journal:  Am J Manag Care       Date:  2021-03-01       Impact factor: 2.229

7.  Differences in Health Care Utilization, Process of Diabetes Care, Care Satisfaction, and Health Status in Patients With Diabetes in Medicare Advantage Versus Traditional Medicare.

Authors:  Sungchul Park; Eric B Larson; Paul Fishman; Lindsay White; Norma B Coe
Journal:  Med Care       Date:  2020-11       Impact factor: 3.178

8.  Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability: An Ancillary Study of the Look AHEAD Study.

Authors:  Peter J Huckfeldt; Chris Frenier; Nicholas M Pajewski; Mark Espeland; Anne Peters; Ramon Casanova; Xavier Pi-Sunyer; Lawrence Cheskin; Dana P Goldman
Journal:  JAMA Netw Open       Date:  2020-11-02

9.  Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors.

Authors:  Jennifer L Lund; Krishnan Bhaskaran; Anthony A Matthews; Sharon Peacock Hinton; Susannah Stanway; Alexander Richard Lyon; Liam Smeeth
Journal:  Heart       Date:  2020-11-11       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.